Table 1 Comparison of demographic profile and serological testing between HIV/AIDS patients with and without CMV colitis
HIV+ CMV (CMV colitis group, n = 20) (mean ± SD; Median; IQR) | HIV (control group, n = 175) (mean ± SD; Median; IQR) | Total | P value | |
|---|---|---|---|---|
Sex | ||||
Male | 18 (90%) | 155 (88.6%) | 173 (88.7%) | 0.848 |
Female | 2 (10%) | 20 (11.4%) | 22 (11.3%) | |
Age (year) | ||||
Average | 39.1 ± 11.2; 41; 27–51 | 37.9 ± 11.6; 35; 29–46 | 38.0 ± 11.6;36; 29–46 | 0.666 |
Serum CD4+ T cells (cells/μL) | 31.3 ± 40.3; 14; 5–46 | 210.6 ± 217.1; 140.5; 24.5–345.5; | – | < 0.001 |
Serum CD8+ T cells (cells/μL) | 531.6 ± 500.6; 468; 123–682 | 746.3 ± 543.1; 617.5; 386.25–918.75 | – | 0.102 |
Leukocyte (109/L) | 5.08 ± 4.51; 3.77; 2.25–5.39 | 5.21 ± 2.61; 4.84; 3.245–6.475 | – | 0.902 |
Erythrocyte (1012/L) | 2.91 ± 0.54; 2.81; 2.47–3.4 | 3.71 ± 0.96; 3.74; 2.97–4.47 | – | < 0.001 |
Hemoglobin (g/L) | 87.3 ± 17.9; 88.4; 72.2–107 | 115.7 ± 30.7; 115; 94–141.1 | – | < 0.001 |
Platelet (109/L) | 189.4 ± 120.3; 173; 118–221.8 | 207.9 ± 83.5; 205.5; 154.95–261.5 | – | 0.385 |
HIV viral load (copies/mL) | 261,939 ± 241,476; 302,918; 53,904–387,750 | 337,875 ± 971,601; 90,565.5; 11,341.25–441,623 | – | 0.764 |